Provided by Tiger Fintech (Singapore) Pte. Ltd.

iHuman

2.28
+0.20009.62%
Volume:115.55K
Turnover:264.46K
Market Cap:119.06M
PE:8.20
High:2.32
Open:2.08
Low:2.08
Close:2.08
Loading ...

iHuman Second Quarter 2024 Earnings: EPS: CN¥0.47 (vs CN¥0.80 in 2Q 2023)

Simply Wall St.
·
28 Sep 2024

Stock Track | iHuman Stock Surges on Growth Prospects Despite Q2 Financial Decline

Stock Track
·
28 Sep 2024

Stock Track | iHuman Stock Soars Despite Mixed Q2 Results on Growth Prospects

Stock Track
·
27 Sep 2024

iHuman Inc. Faces Mixed Q2 2024 Financial Results

TIPRANKS
·
27 Sep 2024

iHuman Q2 Adj EPADS $0.06 Down From $0.11 YoY, Sales $29.60M Down From $33.23M YoY

Benzinga
·
27 Sep 2024

Ihuman Q2 Gross Margin 70.5%

THOMSON REUTERS
·
27 Sep 2024

Ihuman Q2 Operating Expenses RMB 132.9 Million

THOMSON REUTERS
·
27 Sep 2024

Ihuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

THOMSON REUTERS
·
27 Sep 2024

Press Release: iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

Dow Jones
·
27 Sep 2024

ZCCM-IH Reports Massive EPS Surge

TIPRANKS
·
26 Sep 2024

Stock Track | iHuman Stock Soars as Investment Conference Generates Buzz

Stock Track
·
26 Sep 2024

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

GlobeNewswire
·
26 Sep 2024

HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024

PR Newswire
·
26 Sep 2024

Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

GlobeNewswire
·
26 Sep 2024

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

GlobeNewswire
·
17 Sep 2024